| Dr Carolyn Keeler, DO | |
|
Dumc 3807, Durham, NC 27710-0001 | |
| (919) 684-7821 | |
| Not Available |
| Full Name | Dr Carolyn Keeler |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 20 Years |
| Location | Dumc 3807, Durham, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083804058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 2009-02079 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duke University Hospital | Durham, NC | Hospital |
| Duke Regional Hospital | Durham, NC | Hospital |
| Duke Health Raleigh Hospital | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
| Duke Health Integrated Practice Inc | 8325412737 | 2551 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company's financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen's 2010 fiscal year.
Immunomedics has reported in an oral presentation at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) that the antigen targeted by the humanized PAM4 antibody is expressed in early stage pancreatic cancer specimens, a stage before the tumor becomes invasive.
New research from the University of British Columbia suggests that reducing mutated Huntington disease protein in the brain can restore cognitive and psychiatric impairments in mice.
Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in adults, researchers from Yale and Albert Einstein College of Medicine report Sept. 18 in the journal Science Translational Medicine.
Northwestern University Feinberg School of Medicine has been awarded a grant from the Walder Foundation via the COVID-19 Fund to Retain Clinical Scientists (FRCS) competition, designed to support policies and practices at U.S. medical schools to advance research productivity and retain early-career clinician investigators experiencing family caregiving challenges due to the COVID-19 pandemic.
› Verified 6 days ago
| Entity Name | Duke University Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558392977 PECOS PAC ID: 2567372345 Enrollment ID: O20031201000521 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company's financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen's 2010 fiscal year.
Immunomedics has reported in an oral presentation at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) that the antigen targeted by the humanized PAM4 antibody is expressed in early stage pancreatic cancer specimens, a stage before the tumor becomes invasive.
New research from the University of British Columbia suggests that reducing mutated Huntington disease protein in the brain can restore cognitive and psychiatric impairments in mice.
Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in adults, researchers from Yale and Albert Einstein College of Medicine report Sept. 18 in the journal Science Translational Medicine.
Northwestern University Feinberg School of Medicine has been awarded a grant from the Walder Foundation via the COVID-19 Fund to Retain Clinical Scientists (FRCS) competition, designed to support policies and practices at U.S. medical schools to advance research productivity and retain early-career clinician investigators experiencing family caregiving challenges due to the COVID-19 pandemic.
› Verified 6 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company's financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen's 2010 fiscal year.
Immunomedics has reported in an oral presentation at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) that the antigen targeted by the humanized PAM4 antibody is expressed in early stage pancreatic cancer specimens, a stage before the tumor becomes invasive.
New research from the University of British Columbia suggests that reducing mutated Huntington disease protein in the brain can restore cognitive and psychiatric impairments in mice.
Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in adults, researchers from Yale and Albert Einstein College of Medicine report Sept. 18 in the journal Science Translational Medicine.
Northwestern University Feinberg School of Medicine has been awarded a grant from the Walder Foundation via the COVID-19 Fund to Retain Clinical Scientists (FRCS) competition, designed to support policies and practices at U.S. medical schools to advance research productivity and retain early-career clinician investigators experiencing family caregiving challenges due to the COVID-19 pandemic.
› Verified 6 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company's financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen's 2010 fiscal year.
Immunomedics has reported in an oral presentation at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) that the antigen targeted by the humanized PAM4 antibody is expressed in early stage pancreatic cancer specimens, a stage before the tumor becomes invasive.
New research from the University of British Columbia suggests that reducing mutated Huntington disease protein in the brain can restore cognitive and psychiatric impairments in mice.
Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in adults, researchers from Yale and Albert Einstein College of Medicine report Sept. 18 in the journal Science Translational Medicine.
Northwestern University Feinberg School of Medicine has been awarded a grant from the Walder Foundation via the COVID-19 Fund to Retain Clinical Scientists (FRCS) competition, designed to support policies and practices at U.S. medical schools to advance research productivity and retain early-career clinician investigators experiencing family caregiving challenges due to the COVID-19 pandemic.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carolyn Keeler, DO Dumc 3807, Durham, NC 27710-0001 Ph: (919) 684-7821 | Dr Carolyn Keeler, DO Dumc 3807, Durham, NC 27710-0001 Ph: (919) 684-7821 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company's financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen's 2010 fiscal year.
Immunomedics has reported in an oral presentation at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) that the antigen targeted by the humanized PAM4 antibody is expressed in early stage pancreatic cancer specimens, a stage before the tumor becomes invasive.
New research from the University of British Columbia suggests that reducing mutated Huntington disease protein in the brain can restore cognitive and psychiatric impairments in mice.
Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in adults, researchers from Yale and Albert Einstein College of Medicine report Sept. 18 in the journal Science Translational Medicine.
Northwestern University Feinberg School of Medicine has been awarded a grant from the Walder Foundation via the COVID-19 Fund to Retain Clinical Scientists (FRCS) competition, designed to support policies and practices at U.S. medical schools to advance research productivity and retain early-career clinician investigators experiencing family caregiving challenges due to the COVID-19 pandemic.
› Verified 6 days ago
Elena Hart, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3643 N Roxboro St, Durham, NC 27704 Phone: 919-470-4000 | |
Raphael S. Orenstein, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 120 William Penn Plz, Durham, NC 27704 Phone: 919-220-5255 Fax: 919-220-6971 | |
Mazen Zein, D.O Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Duke Medicine Circle Spine Center Clinic 1b/1c, Durham, NC 27710 Phone: 919-660-3006 | |
Shane Sullivan, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 4221 Garrett Rd, Durham, NC 27707 Phone: 919-937-9607 | |
Dr. Paul Edwind Howell Jr., M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 508 Fulton St # 117, Durham, NC 27705 Phone: 919-286-0411 Fax: 919-416-5913 | |
Eugenia Fay Zimmerman, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 120 William Penn Plz, Durham, NC 27704 Phone: 919-220-5255 Fax: 919-220-6971 |